Abstract
Objective: Present a review about the use of mechanical pulmonary ventilation in Hypertension Pulmonary Persistent Neonatal (HPPN), the conventional mode and the indication of high-frequency oscillatory ventilation (HFOV). Also present other approaches, such as therapeutics use of exogenous surfactant, inhaled nitric oxide, phosphodiesterases inhibitors and extracorporeal membrane oxygenation. Data Source: It has been used in articles obtained in the Pub Med, Medline, Cochrane BVS, databases, in which there are topics about mechanical ventilation in Hypertension Pulmonary Persistent Neonatal and others treatments used in the newborn with HPPN. Conclusion: The effective treatments used in HPPN are a conventional, not very aggressive ventilatory strategy; HFOV; inhaled nitric oxide and vasodilators medications that act on the lungs rather than on the whole system, and, in newborns that do not respond to these treatments, the use of extracorporeal membrane oxygenation.
Keywords: Mechanical ventilation, hypertension pulmonary persistent neonatal, exogenous surfactant, nitric oxide, phosphodiesterases inhibitors, vasoreactivity, PFC syndrome, high-frequency oscillatory ventilation, coarctation of the aorta, meconium aspiration syndrome
Current Respiratory Medicine Reviews
Title: Ventilatory Support in Persistent Pulmonary Hypertension of the Newborn
Volume: 8 Issue: 1
Author(s): Maria Esther Jurfest Ceccon and Werther Brunow de Carvalho
Affiliation:
Keywords: Mechanical ventilation, hypertension pulmonary persistent neonatal, exogenous surfactant, nitric oxide, phosphodiesterases inhibitors, vasoreactivity, PFC syndrome, high-frequency oscillatory ventilation, coarctation of the aorta, meconium aspiration syndrome
Abstract: Objective: Present a review about the use of mechanical pulmonary ventilation in Hypertension Pulmonary Persistent Neonatal (HPPN), the conventional mode and the indication of high-frequency oscillatory ventilation (HFOV). Also present other approaches, such as therapeutics use of exogenous surfactant, inhaled nitric oxide, phosphodiesterases inhibitors and extracorporeal membrane oxygenation. Data Source: It has been used in articles obtained in the Pub Med, Medline, Cochrane BVS, databases, in which there are topics about mechanical ventilation in Hypertension Pulmonary Persistent Neonatal and others treatments used in the newborn with HPPN. Conclusion: The effective treatments used in HPPN are a conventional, not very aggressive ventilatory strategy; HFOV; inhaled nitric oxide and vasodilators medications that act on the lungs rather than on the whole system, and, in newborns that do not respond to these treatments, the use of extracorporeal membrane oxygenation.
Export Options
About this article
Cite this article as:
Esther Jurfest Ceccon Maria and Brunow de Carvalho Werther, Ventilatory Support in Persistent Pulmonary Hypertension of the Newborn, Current Respiratory Medicine Reviews 2012; 8 (1) . https://dx.doi.org/10.2174/157339812798868834
DOI https://dx.doi.org/10.2174/157339812798868834 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Adiponectin as a Regulator of Vascular Redox State: Therapeutic Implications
Recent Patents on Cardiovascular Drug Discovery Pathophysiology of Thrombosis and Potential Targeted Therapies in Antiphospholipid Syndrome
Current Vascular Pharmacology The Different Roles of The Channel-Kinases TRPM6 and TRPM7
Current Medicinal Chemistry Xanthan Gum and Its Derivatives as a Potential Bio-polymeric Carrier for Drug Delivery System
Current Drug Delivery Targeting Bacterial Metalloenzymes: A New Strategy for the Development of Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry Natriuretic Peptides in Coronary Disease With Non-ST Elevation: New Tools Ready for Clinical Application?
Recent Patents on Cardiovascular Drug Discovery Ketamine: New Indications for an Old Drug
Current Drug Targets Inhibition of Zinc Metallopeptidases in Cardiovascular Disease - From Unity to Trinity, or Duality?
Current Pharmaceutical Design Cellular and Functional Effects of Insulin Based Therapies and Exercise on Endothelium
Current Pharmaceutical Design Is Hypertension an Inflammatory Process?
Current Pharmaceutical Design Statins Influence Long Term Restenosis and Cardiovascular Events Following Carotid Endarterectomy
Current Vascular Pharmacology Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis
Current Pharmaceutical Biotechnology Medical Treatment of Primary, Secondary, and Tertiary Hyperparathyroidism
Current Drug Safety Improving of Nutraceutical Features of Many Important Mediterranean Vegetables by Inoculation with a New Commercial Product
Current Pharmaceutical Biotechnology Development and Validation of a Reliable LC-MS/MS Method for Simultaneous Quantification of Hydrochlorothiazide in the Presence of Different Co-formulated Anti-hypertensive Medications in Biological Matrix
Current Pharmaceutical Analysis The Role of Endothelial Dysfunction in Aortic Aneurysms
Current Pharmaceutical Design Postmenopausal Hypertension: Insights from Rat Models
Current Hypertension Reviews Mild Parkinsonian Signs in a Hospital-based Cohort of Mild Cognitive Impairment Types: A Cross-sectional Study
Current Alzheimer Research Beta-blockers in Intensive Care Medicine: Potential Benefit in Acute Brain Injury and Acute Respiratory Distress Syndrome
Recent Patents on Cardiovascular Drug Discovery Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives
Current Pharmaceutical Design